Martek profits fall, CEO to retire -
Washington Business Journal
Rachel Sams Contributing Writer
Martek Biosciences reported fourth-quarter earnings of $5 million, down from more than $35 million in profit last year. The Columbia-based bioscience company also disclosed that CEO Henry 'Pete' Linsert Jr. will retire next summer. Linsert has been CEO since 1989. He will remain chairman of the firm, the company said. Martek said its president, Steve Dubin, will succeed Linsert as CEO. ..."